21 November 2019
: Case report
Rivaroxaban-Induced Acute Interstitial Nephritis: A Case Report
Challenging differential diagnosis, Unexpected drug reaction , Educational Purpose (only if useful for a systematic review or synthesis)
Fahad Zafar1ABCDEF*, Arshad Muhammad Iqbal1ABCDEF, Ateeq Mubarik1ABCDEF, Melanie Rojas1ABCDEF, Salman Muddassir1ABCDEFDOI: 10.12659/AJCR.917492
Am J Case Rep 2019; 20:1719-1722
Abstract
BACKGROUND: Direct oral anticoagulant agents (DOACs) have become increasingly more popular in recent years and have largely replaced warfarin in the treatment of certain conditions, such as atrial fibrillation, and in the prevention of thromboembolic events. Rivaroxaban is one of the most commonly used direct anticoagulant drugs for conditions such as atrial fibrillation and thromboprophylaxis.
CASE REPORT: We present a case of a 70-year-old male who developed acute interstitial nephritis after starting rivaroxaban, and who responded to medical treatment, which included corticosteroid therapy. A renal biopsy was not performed because the patient was on essential anticoagulation therapy secondary to a high CHADS2VASc score.
CONCLUSIONS: Dose adjustments when using rivaroxaban are necessary in patients with underlying renal failure. Acute interstitial nephritis is a rare condition associated with direct anticoagulant drugs. The treatment of acute interstitial nephritis is usually to remove the offending agent and treat the underlying cause.
Keywords: Anticoagulants, Drug-Related Side Effects and Adverse Reactions, Nephrology, Aged, Atrial Fibrillation, Creatinine, Diagnosis, Differential, Factor Xa Inhibitors, Glucocorticoids, Methylprednisolone, Nephritis, Interstitial, Renal Insufficiency, Chronic, Rivaroxaban
SARS-CoV-2/COVID-19
11 August 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936496
09 August 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937505
29 July 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937105
08 July 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937212
In Press
18 Aug 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937195
17 Aug 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936537
16 Aug 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937511
16 Aug 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937598
Most Viewed Current Articles
13 Jul 2022 : Case report
DOI :10.12659/AJCR.936441
Am J Case Rep 2022; 23:e936441
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
17 Feb 2022 : Case report
DOI :10.12659/AJCR.934399
Am J Case Rep 2022; 23:e934399